News

The Hyderabad-based Aurobindo Pharma is expected to sign an agreement regarding this with Pfizer, reported The Financial Express. Currently, Aurobindo is in pact with Pfizer for the marketing

Under the terms of their partnership agreement signed in January 2010, Inspiration in-licensed OBI-1 from Ipsen, and is responsible for the clinical development, regulatory process and commercialisation of

The first product in the new line is Allegro CTMS@Site, the clinical trials management system built exclusively for investigational sites. Forte Research claimed that the Allegro product line

Under terms of the agreement, Cardium will identify a line of products applying BioZone technology such as that incorporated into its QuSome, Inflacin, LipoCeutical, LipoSpray and other formulation

Agennix has posted a net loss of EUR11.2m for the third quarter 2010, or EUR0.54 loss per diluted share, compared to net loss of EUR2.14m, or EUR0.29 loss

Advanced Life Sciences claimed that ALS-886 is a small molecule therapeutic that, in preclinical studies, has demonstrated efficacy in both scavenging existing free radicals and sequestering free iron.

Amgen said that Xgeva is a fully human monoclonal antibody that binds to RANK Ligand, a protein essential for the formation, function and survival of osteoclasts (the cells

BMS and Pfizer said that the study was stopped early based on the recommendation of an independent Data Monitoring Committee (DMC). There was clear evidence of a clinically

The study, conducted by Intercell’s collaborator, a subsidiary of Merck, was designed to evaluate the safety and immunogenicity of V710 in patients with end-stage renal disease (ESRD) undergoing